Frontotemporal lobar degeneration with MAPT pathogenic variants (FTLD-MAPT) has heterogeneous tau pathological inclusions postmortem, consisting of three-repeat (3R) or four-repeat (4R) tau isoforms, or a combination (3R + 4R). Here, we studied grey matter tau burden, its relation to neuronal degeneration, and regional patterns of pathology in different isoform groups of FTLD-MAPT. We included 38 FTLD-MAPT autopsy cases with 10 different MAPT pathogenic variants, grouped based on predominant tau isoform(s). In up to eleven regions (ten cortical and one striatal), we quantified grey matter tau burden using digital histopathological analysis and assigned semi-quantitative ratings for neuronal degeneration (i.e. 0–4) and separate burden of gli...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
Frontotemporal lobar degeneration with MAPT pathogenic variants (FTLD-MAPT) has heterogeneous tau pa...
Tau aggregation is a hallmark feature in a subset of patients with frontotemporal dementia (FTD). Ea...
Frontotemporal lobar degeneration (FTLD) has been associated with toxic intracellular aggregates of ...
Abstract Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is associated with the ...
Frontotemporal lobar degeneration (FTLD) consists of a group of neurodegenerative diseases character...
The ‘prion-like’ transfer of pathogenic proteins may play a role in the pathogenesis of frontotempor...
Frontotemporal dementia is a term used to characterize diverse neuropathological conditions that can...
See Josephs (doi:10.1093/brain/awx367) for a scientific commentary on this article.In many neurodege...
International audienceAbstractReduction of Tau protein expression was described in 2003 by Zhukareva...
International audienceAbstractReduction of Tau protein expression was described in 2003 by Zhukareva...
International audienceAbstractReduction of Tau protein expression was described in 2003 by Zhukareva...
Abstract: Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous neurodegene...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
Frontotemporal lobar degeneration with MAPT pathogenic variants (FTLD-MAPT) has heterogeneous tau pa...
Tau aggregation is a hallmark feature in a subset of patients with frontotemporal dementia (FTD). Ea...
Frontotemporal lobar degeneration (FTLD) has been associated with toxic intracellular aggregates of ...
Abstract Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is associated with the ...
Frontotemporal lobar degeneration (FTLD) consists of a group of neurodegenerative diseases character...
The ‘prion-like’ transfer of pathogenic proteins may play a role in the pathogenesis of frontotempor...
Frontotemporal dementia is a term used to characterize diverse neuropathological conditions that can...
See Josephs (doi:10.1093/brain/awx367) for a scientific commentary on this article.In many neurodege...
International audienceAbstractReduction of Tau protein expression was described in 2003 by Zhukareva...
International audienceAbstractReduction of Tau protein expression was described in 2003 by Zhukareva...
International audienceAbstractReduction of Tau protein expression was described in 2003 by Zhukareva...
Abstract: Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous neurodegene...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...
BACKGROUND: An increasing number of recently described tau mutations show considerable clinical hete...